Whitepaper:

Turning Innovation into Predictable Cash Flow

How CFOs use public funding programmes as a strategic financial tool

What you can expect from this white paper

 

Companies with annual R&D expenditure of 5 million euros can achieve an annual cash inflow of between 1.05 and 1.4 million euros through the research tax credit, plus a one-off retrospective benefit of up to 5.6 million euros. Most fail to capitalise on this potential.
Not because they are ineligible for funding, but because three structural flaws prevent systematic utilisation: funding is treated as a project rather than a process, finance and R&D operate in silos, and liquidity effects are excluded from financial planning.

 

The result is a structural governance deficit with direct implications for cash flow, margins and audit assurance.
This white paper is aimed at CFOs and finance managers who view funding not as a grant application, but as a financial instrument. It explains why most approaches fail and how a group-wide process specifically impacts the profit and loss account, cash flow and equity ratio.

The Reality of Being a CFO & the Typical Pitfalls

Figures that matter: the real liquidity leverage

The 5-step approach to corporate security

Download the white paper now

 Download our white paper now. It shows you how to systematically unlock the potential for annual savings running into millions on your R&D costs, why the typical silos between Finance and R&D jeopardise your funding, and how a group-wide process can sustainably strengthen your profit and loss account, liquidity and audit assurance.